Asher Biotherapeutics, Inc. — Form D
Asher Biotherapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-16. The offering totals $55.0M, of which $55.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-04-16
- Form: D
- Accession: 0001787260-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $55.0M
- Amount sold: $55.0M
- Investors: 16
- Date of first sale: 2024-04-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-510726
Issuer
- Name: Asher Biotherapeutics, Inc.
- CIK: 0001787260
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 650 GATEWAY BLVD., SUITE 100, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-628-8110
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Ian Clark | Director | SOUTH SAN FRANCISCO, CA |
| Bob Deresiewicz | Director | SOUTH SAN FRANCISCO, CA |
| Ivana Djuretic | Director | SOUTH SAN FRANCISCO, CA |
| Craig Gibbs | Director | SOUTH SAN FRANCISCO, CA |
| Reid Huber | Director | Boston, MA |
| Elaine Sun | Director | SOUTH SAN FRANCISCO, CA |
| Jeffrey Tong | Director | San Francisco, CA |
| Ivana Djuretic | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Kyle Elrod | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Craig Gibbs | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Don O'Sullivan | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Andy Yeung | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Ivana Djuretic | Promoter | SOUTH SAN FRANCISCO, CA |
| Yik Andy Yeung | Director | South San Francisco, CA |
| Yik Andy Yeung | Executive Officer | South San Francisco, CA |
| Yik Andy Yeung | Promoter | South San Francisco, CA |
Other filings by this issuer (2)
More